Randomized, Open Label, Crossover Study to Evaluate the Relative Bioavailability of a New Tablet Formulation of CIN-107 as Compared to Oral Solution and to Assess the Effect of Food on the CIN-107 Tablet Formulation in Healthy Subjects
Latest Information Update: 16 Aug 2023
At a glance
- Drugs Baxdrostat (Primary) ; Baxdrostat
- Indications Hypertension
- Focus Adverse reactions; Pharmacokinetics
- Sponsors AstraZeneca; CinCor Pharma
Most Recent Events
- 01 Aug 2023 New trial record